Rockville, Maryland – October 27, 2026 – The global benign prostatic hyperplasia (BPH) treatment market is projected to increase from USD 33.7 billion in 2026 to USD 54.8 billion by 2036, registering a compound annual growth rate (CAGR) of 5.0%, according to Fact.MR. The market is expected to create an incremental opportunity of USD 21.1 billion over the forecast period as demand...